MMED thoughtsso these are the areas that im looking for support in to determine if the trend is going bullish, or not.
Mmed
MMED Remaining Bullish on the daily!MMED had a perfect bounce on the daily EMA ribbon and off the 0.5 fibonacci level today. CRazy how they lined up perfectly today. I first bought MMED at 52 cents and I got some more filled today on this pullback. I am extremely bullish on this stock and the entire psychedelic space moving into the next few years. Current anxiety and depression medications absolutely suck and I believe Psilocybin can make a major difference in people's lives!
TRIP, the baby MMED that will hit soon 1$Hello again fellow Bulls, most of you probably ask the same question, where can I get a similar stock like MMED, well I am here to tell you that TRIP is baby MMED and moves 2 times stronger when MMED moves. However, before you put any money into this penny stock, understand that I do not know their long-term plans nor I am confident they are even a good company. My opinion here is only to alert you all that MMED strongly influences this stock to rise because of the trend and I clearly see this stock hitting 1$ once MMED announcing NASDAQ or opens at NASDAQ. But do understand that TRIP is much risky than MMED and it may bring you 2 times more profits, it also brings you a bigger risk. I would bag-hold this stock only for the trend and not for any future ideas that this company have. What I am doing, is putting only 1/5 or 1/6 of my portfolio into this stock, the rest I keep at MMED. We should hit 1$ at a time limit of 2 months. Good luck fellows.
MMED almost at NASDAQHello fellow Bulls, hope you caught the train on MMED and any psychedelic stocks before they left the station, the volatility I witnessed on MMED is quite scary, specially the last 2 days that were a 30% drop. However, the public deal announcement that drove the stock 30% down was a necessary move to get cash. Without cash, this company wont survive, that's why they are getting it and a lot of it. They need it to pay not only the management of the company but also to acquire new information, data, tools and people that specialize in psychedelics which can costs millions of dollars, specially when they have to acquire other small companies for these resources. Anyway, I am here to give you all another possible hit point we can achieve by holding this stock. I predict the stock to reach up to 10$ per share on NASDAQ announcement and 20$ on NASDAQ opening. There is still place of growth and while the stock now at 4.5$, it is still a green go to buy it. The worst already behind, the stock stabilized at price of 4$ and will have a good checkpoint to start rising from. The NASDAQ news is still unknown but lets hope it will come soon, I'd say maybe maximum 2 months of waiting. I bag-hold myself already 14000 shares from 1$ and still wait for the NASDAQ news. Another tip I would recommend to people who can afford less, buy TRIP, I can't say their reliability for long term but the stock is super cheap at 0.38 cents a share and if MMED will rise up, TRIP will be on its back rising the double. Good luck mates.
Kevin O'leary adopted brainchild, Swing TradeJust another great company, in a sector that is about to go. Pscychodelics(Pharama). They are alreay in the cannabis market, however they are geared towards the next frontier, lsd, psylocibin, etc.
Its a swing trade, enter below a dolar, as it corrects violently. If it bounces of the dolar as tsx_trader is suggesting go all in to the next resistance, otherwise 80sh cents its a grea entry point.
Good Luck, definatly a hold once you enter, sell once it doubles and buy the correection again.
MMEDF UpdateCould see more consolidation if buy volume doesn't come in, but currently looking strong. Please consider leaving a like and following the account for more psychedelic pharmaceutical TA. Just my opinion, I can be wrong please do not trade without evaluating your own opinion.
On the fundamental side, MindMed Conference Call went excellent. They are on pace with their trials and have a strong cash balance.
Potential descending channel for MMED?The green upward sloping line of support is potentially keeping a bullish flag in play here, but it appears as though downward pressure is indicating there may be a retest of the bottom blue channel where I have the red arrow pointing down.
KEY TAKEAWAYS
A descending channel is drawn by connecting the lower highs and lower lows of a security's price with parallel trendlines to show a downward trend.
Traders who believe a security is likely to remain within its descending channel can initiate trades when the price fluctuates within its channel trendline boundaries.
A more potent signal occurs with a breakout, which is when a security's price breaches an established channel's boundaries, either on the upper or lower side.
MMED day 1 121%Mind Med is the first psychedelic company to IPO. Backed by big names from big brands, Shark Tank and Tom's Shoes and Canopy Growth. MMED has in its portfolio (1) psychedelic-derived drug for the treatment of opiate addiction made from indigenous African plant iboga used in religious rituals for thousands of years (2) LSD microdosing trials.
+
10x potential.
-
Most private sale investors have no lockup. Last week the company did a pre-IPO round at $0.33 for about $24M
